Table 2.
Median (interquartile range) | |||
---|---|---|---|
Overall | Incident users | Prevalent users | |
Subjects | n = 74 272 | n = 52 671 | n = 21 601 |
Total follow‐up time (years) | 9.2 (4.2,13.8) | 11.3 (7.1,15.3) | 3.1 (1.1,7.2) |
Exposed follow‐up time (years) | 6.9 (2.4,12.2) | 9.6 (5.5,13.7) | 1.0 (0.2,3.0) |
Time after discontinuation (years) | 1.3 (0.2,4.2) | 1.0 (0.2,3.4) | 2.2 (0.3,6.8) |
Mean daily dose (mg) | 25 (25,50) | 25 (25,50) | 47 (25,75) |
Coverage (%) | 98 (79,100) | 99 (81,100) | 96 (74,100) |